Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-24-028538
Filing Date
2024-12-06
Accepted
2024-12-06 17:45:05
Documents
1
Period of Report
2024-12-05

Document Format Files

Seq Description Document Type Size
1 form4-12062024_051201.html 4  
1 form4-12062024_051201.xml 4 3942
  Complete submission text file 0001415889-24-028538.txt   5408
Mailing Address 1601 TRAPELO ROAD SUITE 286 WALTHAM MA 02451
Business Address 1601 TRAPELO ROAD SUITE 286 WALTHAM MA 02451 617-600-7373
Minerva Neurosciences, Inc. (Issuer) CIK: 0001598646 (see all company filings)

EIN.: 260784194 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O MINERVA NEUROSCIENCES, INC. 1601 TRAPELO ROAD, SUITE 286 WALTHAM MA 02451
Business Address
Luthringer Remy (Reporting) CIK: 0001610384 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36517 | Film No.: 241533383